Avoro Capital Advisors LLC Q1 2022 Filing
Filed May 16, 2022
Portfolio Value
$5.5T
Holdings
43
Report Date
Q1 2022
Filing Type
13F-HR
All Holdings (43 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | HZNPHORIZON THERAPEUTICS PLC | 6,500,000 | $683.9B | 12.48% | |
| 2 | UTHUNITED THERAPEUTICS CORP | 3,030,000 | $543.6B | 9.92% | |
| 3 | APLSAPELLIS PHARMACEUTICALS INC | 9,450,000 | $480.2B | 8.77% | |
| 4 | MRTXEURMIRATI THERAPEUTICS INC | 5,325,000 | $437.8B | 7.99% | |
| 5 | ARGXARGENX SE | 1,255,000 | $395.7B | 7.22% | |
| 6 | XBISPDR SERIES TRUST - S&P BIOTECH | 3,050,000 | $274.1B | 5.00% | |
| 7 | ASNDASCENDIS PHARMA | 2,200,000 | $258.2B | 4.71% | |
| 8 | SRPTSAREPTA THERAPEUTICS INC | 3,135,000 | $244.9B | 4.47% | |
| 9 | BMRNBIOMARIN PHARMACEUTICAL INC | 3,035,000 | $234.0B | 4.27% | |
| 10 | ALNYALNYLAM PHARMACEUTICALS INC | 1,300,000 | $212.3B | 3.88% | |
| 11 | AM6AMICUS THERAPEUTICS INC | 20,500,000 | $194.1B | 3.54% | |
| 12 | SGENUSDSEAGEN INC | 1,315,000 | $189.4B | 3.46% | |
| 13 | XENEXENON PHARMACEUTICALS INC | 4,985,000 | $152.4B | 2.78% | |
| 14 | IOVAIOVANCE BIOTHERAPEUTICS INC | 9,125,000 | $151.9B | 2.77% | |
| 15 | MDGLMADRIGAL PHARMACEUTICALS INC | 1,425,000 | $139.8B | 2.55% | |
| 16 | OPHTEURIVERIC BIO INC | 7,250,000 | $122.0B | 2.23% | |
| 17 | KURAKURA ONCOLOGY INC | 4,800,000 | $77.2B | 1.41% | |
| 18 | KRYSKRYSTAL BIOTECH INC | 1,005,000 | $66.9B | 1.22% | |
| 19 | ACADACADIA PHARMACEUTICALS INC | 2,275,000 | $55.1B | 1.01% | |
| 20 | GLUEMONTE ROSA THERAPEUTICS INC | 3,311,434 | $46.4B | 0.85% | |
| 21 | PMVPPMV PHARMACEUTICALS INC | 2,200,000 | $45.8B | 0.84% | |
| 22 | SNDXSYNDAX PHARMACEUTICALS INC | 2,220,500 | $38.6B | 0.70% | |
| 23 | DSGNDESIGN THERAPEUTICS INC | 2,222,222 | $35.9B | 0.66% | |
| 24 | KYMRKYMERA THERAPEUTICS INC | 816,500 | $34.6B | 0.63% | |
| 25 | MNKDMANNKIND CORP | 8,800,000 | $32.4B | 0.59% | |
| 26 | CBAYUSDCYMABAY THERAPEUTICS INC | 10,300,000 | $32.0B | 0.58% | |
| 27 | WHWKAADI BIOSCIENCES INC | 1,829,402 | $31.0B | 0.57% | |
| 28 | BCRXBIOCRYST PHARMACEUTICLAS INC | 1,875,000 | $30.5B | 0.56% | |
| 29 | MRNS*MARINUS PHARMACEUTICALS INC | 3,150,000 | $29.5B | 0.54% | |
| 30 | —MERSANA THERAPEUTICS INC | 6,800,000 | $27.1B | 0.50% | |
| 31 | RNAAVIDITY BIOSCIENCES INC | 1,300,000 | $24.0B | 0.44% | |
| 32 | PRAXPRAXIS PRECISION MEDICINES INC | 2,150,000 | $22.0B | 0.40% | |
| 33 | —DICE THERAPEUTICS INC | 1,075,000 | $20.6B | 0.38% | |
| 34 | AMRNAMARIN CORP PLC | 6,000,000 | $19.7B | 0.36% | |
| 35 | RAREULTRAGENYX PHARMACEUTICAL INC | 230,000 | $16.7B | 0.30% | |
| 36 | NUVLNUVALENT INC | 1,049,471 | $14.6B | 0.27% | |
| 37 | TNGXTANGO THERAPEUTICS INC | 1,550,000 | $11.7B | 0.21% | |
| 38 | AVDLAVADEL PHARMACEUTICALS PLC | 1,670,000 | $11.4B | 0.21% | |
| 39 | IOBTIO BIOTECH INC | 2,055,883 | $9.6B | 0.17% | |
| 40 | ADVMCHFADVERUM BIOTECHNOLOGIES INC | 6,950,000 | $9.1B | 0.17% | |
| 41 | —APPLIED MOLECULAR TRANS INC | 1,030,000 | $7.7B | 0.14% | |
| 42 | FRXFENNEC PHARMACEUTICALS INC | 1,200,000 | $6.7B | 0.12% | |
| 43 | GNCAQGENOCEA BIOSCIENCES INC | 5,084,184 | $6.4B | 0.12% |